Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3Apr 18, 2007View HTMLDownload DOCDownload PDFDownload XLS
PRE 14AA preliminary proxy statement providing notification matters to be brought to a voteApr 17, 2007View HTMLDownload DOCDownload PDFDownload XLS
10-K/AAmendment to a previously filed 10-KApr 16, 2007View HTMLDownload DOCDownload PDFDownload XLS
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3Apr 16, 2007View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventApr 13, 2007View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesApr 11, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 9, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 4, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 9, 2007View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventMar 2, 2007View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesMar 2, 2007View HTMLDownload DOCDownload PDF
10-KAnnual report which provides a comprehensive overview of the company for the past yearFeb 28, 2007View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesFeb 23, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 22, 2007View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventFeb 20, 2007View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesFeb 16, 2007View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 14, 2007View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GFeb 14, 2007View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GFeb 14, 2007View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GFeb 13, 2007View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventJan 29, 2007View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJan 5, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 3, 2007View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-98

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information